These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 38551099)

  • 61. Sexually transmitted diseases in people living with HIV after implementation of cost coverage of HIV pre-exposure prophylaxis by statutory health insurance in Germany.
    Schuettfort G; Groh A; Kann G; Haberl A; Herrmann E; Wetzstein N; Vehreschild MJGT; Stephan C
    HIV Med; 2023 Feb; 24(2):163-169. PubMed ID: 35859321
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Doxycycline post-exposure prophylaxis for prevention of sexually transmitted infections among Kenyan women using HIV pre-exposure prophylaxis: study protocol for an open-label randomized trial.
    Stewart J; Bukusi E; Sesay FA; Oware K; Donnell D; Soge OO; Celum C; Odoyo J; Kwena ZA; Scoville CW; Violette LR; Morrison S; Simoni J; McClelland RS; Barnabas R; Gandhi M; Baeten JM
    Trials; 2022 Jun; 23(1):495. PubMed ID: 35710444
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Sexually Transmitted Infections Among Men and Transgender Women Using HIV Pre-exposure Prophylaxis in a Large Integrated Health System-A Cohort Study.
    Hechter RC; Bruxvoort KJ; Zhou H; Towner WJ; Contreras R; Schumacher CM; Grant DL; Jones J
    J Acquir Immune Defic Syndr; 2022 Sep; 91(1):1-8. PubMed ID: 35499561
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Multifactorial Correlates of Incident Bacterial Sexually Transmitted Infections Among Black Men Who Have Sex With Men Recruited in 6 US Cities (HIV Prevention Trials Network 061).
    Allan-Blitz LT; Menza TW; Cummings V; Gaydos CA; Wilton L; Mayer KH
    Sex Transm Dis; 2021 Oct; 48(10):720-725. PubMed ID: 34110740
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Facing increased sexually transmitted infection incidence in HIV preexposure prophylaxis cohorts: what are the underlying determinants and what can be done?
    Kenyon C; Van Dijck C; Florence E
    Curr Opin Infect Dis; 2020 Feb; 33(1):51-58. PubMed ID: 31789694
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Prevalence, incidence and predictors of anal
    Goddard SL; Poynten IM; Petoumenous K; Jin F; Hillman RJ; Law C; Roberts JM; Fairley CK; Garland SM; Grulich AE; Templeton DJ;
    Sex Transm Infect; 2019 Nov; 95(7):477-483. PubMed ID: 31018992
    [TBL] [Abstract][Full Text] [Related]  

  • 67. HIV Pre-Exposure Prophylaxis (PrEP) purchase patterns and STI occurrence among Israeli men: A cohort analysis.
    Chemtob D; Weil C; Hannink Attal J; Hawila E; Noff Sadeh E
    PLoS One; 2021; 16(11):e0259168. PubMed ID: 34793473
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Incidence of sexually transmitted infections before and after preexposure prophylaxis for HIV.
    Nguyen VK; Greenwald ZR; Trottier H; Cadieux M; Goyette A; Beauchemin M; Charest L; Longpré D; Lavoie S; Tossa HG; Thomas R
    AIDS; 2018 Feb; 32(4):523-530. PubMed ID: 29239887
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Sexually transmitted infections diagnosed in individuals presenting for forensic and medical care following sexual assault.
    Parekh VR; Martin SJ; Tyson A; Brkic A; McMinn J; Beaumont C; Bowden FJ
    Sex Transm Infect; 2024 Jan; 100(1):45-47. PubMed ID: 38050157
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Australian consensus statement on doxycycline post-exposure prophylaxis (doxy-PEP) for the prevention of syphilis, chlamydia and gonorrhoea among gay, bisexual and other men who have sex with men.
    Cornelisse VJ; Riley B; Medland NA
    Med J Aust; 2024 Apr; 220(7):381-386. PubMed ID: 38479437
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Gonorrhoea and chlamydia diagnosis as an entry point for HIV pre-exposure prophylaxis: a modelling study.
    Kasaie P; Schumacher CM; Jennings JM; Berry SA; Tuddenham SA; Shah MS; Rosenberg ES; Hoover KW; Gift TL; Chesson H; German D; Dowdy DW
    BMJ Open; 2019 Mar; 9(3):e023453. PubMed ID: 30837248
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Inequities Along the Human Immunodeficiency Virus (HIV) Pre-exposure Prophylaxis Services Continuum for Black Women in the United States, 2015-2020.
    Townes A; Tanner MR; Yu L; Johnson WD; Zhu W; Iqbal K; Dominguez KL; Henny KD; Drezner K; Schumacher C; Bickham J; Elopre L; Edelstein ZR; Hoover KW;
    Obstet Gynecol; 2024 Feb; 143(2):294-301. PubMed ID: 37963384
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Preexposure Prophylaxis for HIV Infection Integrated With Municipal- and Community-Based Sexual Health Services.
    Liu AY; Cohen SE; Vittinghoff E; Anderson PL; Doblecki-Lewis S; Bacon O; Chege W; Postle BS; Matheson T; Amico KR; Liegler T; Rawlings MK; Trainor N; Blue RW; Estrada Y; Coleman ME; Cardenas G; Feaster DJ; Grant R; Philip SS; Elion R; Buchbinder S; Kolber MA
    JAMA Intern Med; 2016 Jan; 176(1):75-84. PubMed ID: 26571482
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Understanding dynamics and overlapping epidemiologies of HIV, HSV-2, chlamydia, gonorrhea, and syphilis in sexual networks of men who have sex with men.
    Omori R; Chemaitelly H; Abu-Raddad LJ
    Front Public Health; 2024; 12():1335693. PubMed ID: 38628844
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The impact of COVID-19-related restrictions in 2020 on sexual healthcare use, pre-exposure prophylaxis use, and sexually transmitted infection incidence among men who have sex with men in Amsterdam, the Netherlands.
    de la Court F; Boyd A; Coyer L; van den Elshout M; de Vries HJC; Matser A; Hoornenborg E; Prins M;
    HIV Med; 2023 Feb; 24(2):212-223. PubMed ID: 36226479
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Sexually transmitted infections among participants in an HIV PrEP adherence trial.
    Bristow CC; Hassan A; Moore DJ; Dubé MP; Corado K; Chow K; Ellorin E; Blumenthal J; Morris SR;
    Int J STD AIDS; 2022 Mar; 33(4):397-403. PubMed ID: 35239448
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Detecting Spatial Cores and Temporal Trends of Repeat STIs to Plan Pre-exposure Prophylaxis (PrEP) Scale-up in DC.
    Das S; Allston A; Kharfen M
    J Acquir Immune Defic Syndr; 2020 Aug; 84(4):372-378. PubMed ID: 32205719
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Sexually Transmitted Infection Testing and Prevalence Before and After Preexposure Prophylaxis Initiation Among Men Aged ≥18 Years in US Private Settings.
    Tao G; Pearson WS; Sullivan JM; Henk HJ; Gift TL
    Sex Transm Dis; 2021 Jul; 48(7):515-520. PubMed ID: 33633074
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Patterns of Chlamydia trachomatis and Neisseria gonorrhoeae in different anatomical sites among Pre-Exposure Prophylaxis (PrEP) users in Brazil.
    Antonini M; Vettore MV; Øgård-Repål A; de Macêdo Rocha D; de Alencar Rocha KA; Elias HC; Barufaldi F; Santana RC; Gir E; Spire B; Reis RK
    BMC Infect Dis; 2024 Feb; 24(1):260. PubMed ID: 38408940
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Cross-sectional assessment of determinants of STIs among men who have sex with men and transgender women in Kigali, Rwanda.
    Twahirwa Rwema JO; Herbst S; Hamill MM; Liestman B; Nyombayire J; Lyons CE; Mugwaneza P; Makuza JD; Sullivan PS; Allen S; Karita E; Baral S
    Sex Transm Infect; 2022 May; 98(3):178-187. PubMed ID: 33958492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.